The trademark application BO-112 Spotlight was filed by HIGHLIGHT THERAPEUTICS S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on September 8, 2020, and it was registered by office on December 17, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on December 2, 2021.
Goods And Services
The mark was filed in class 42 with following description of goods:
Providing scientific and research information relating to pharmaceuticals
Providing scientific and research information relating to anti-cancer drugs and anti-cancer drug combinations
Providing scientific and research information relating to resistance or insensitivity of cancer to pharmaceuticals.
The mark was filed in class 44 with following description of goods:
Providing medical information and services relating to pharmaceuticals
Internet-based medical information services and other advisory services in the field of health
Providing medical information and services relating to treatment of cancers and of drug-resistant cancers
Providing medical information and services relating to use of drug and therapy combinations for treating cancer
Providing information to patients in the field of administering anti-cancer drugs and anti-cancer drug combinations
Providing treatments for participants in clinical trials for oncology therapies.